This faux cancer treatment never really stood a chance of obtaining UK Approval.
As I said in Dec 2023, it started to derail almost immediately upon submission.
The protracted ' cut n paste' P3 clinical trial and bastardised data collated, failed to meet the minimum ethical standard required.
It screamed a 'vested interest grift'
As such, the MHRA is simply kicking this can down the road, until a higher authority tells it to pull the plug on the whole UK NWBO affiliate enterprise.
So let's get real. If the Regulator thought that this 'vaccine' had been proven to repeatedly work to any real measurable degree , it would have been granted a MAA by now.
Market Data 
Markets 
AI
